Clinical Care Options Oncology - Evolving Treatment Paradigms for GIST: Current Approaches and Agents on the Horizon

Gastrointestinal Stromal Tumors

Faculty:

Ricardo J. Gonzalez, MD

CREDIT INFORMATION

Release Date: December 15, 2009

Expiration Date: December 14, 2010

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: Please log in to view status

Ricardo J. Gonzalez, MD, explores the biology of gastrointestinal tumors, the currently available treatment options, and the novel agents under investigation for this disease.

Learning Objectives

Upon completion of this activity, participants should be able to:

Evaluate the molecular pathogenesis and the biomarkers associated with GIST
Assess the currently approved treatment options for GIST
Interpret the role of resection in the management of patients with GIST
Distinguish the novel agents under investigation for GIST

Abstract

Click here to view abstract

Interactive Virtual Presentation

Optimal Treatment Approaches for GIST

Faculty:

Jonathan C. Trent, MD, PhD

CREDIT INFORMATION

Release Date: March 31, 2010

Expiration Date: March 30, 2011

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Status: Please log in to view status

Watch, listen, and make treatment decisions as Jonathan C. Trent, MD, PhD, leads you through a case-based interactive presentation exploring the best strategies for treating patients with GIST.

Learning Objectives

Upon completion of this activity, participants should be able to:

Evaluate progressive disease risk according to tumor parameters when managing patients with GIST
Apply clinical trial data on the optimal use of adjuvant therapy when treating patients with resected, primary, KIT-positive GIST
Compare different evidence-based treatment options for patients with metastatic GIST
Interpret the latest findings from clinical studies on approved and investigational second-line agents for patients with imatinib-resistant/intolerant GIST

Disclaimer: The materials published on the Clinical Care Options Sites reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.